Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

Description

This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin. Use of CGM has been shown to improve health outcomes, but is not used by adolescents of color. Peer mentors may help improve usage.

Conditions

Type 1 Diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin. Use of CGM has been shown to improve health outcomes, but is not used by adolescents of color. Peer mentors may help improve usage.

Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

Condition
Type 1 Diabetes
Intervention / Treatment

-

Contacts and Locations

New Haven

Yale Children's Diabetes Clinic, New Haven, Connecticut, United States, 06520

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of type 1 diabetes, as determined clinically by the presence of ketosis or ketoacidosis at presentation and/or the presence of at least one diabetes-related auto-antibody
  • * Self-identification as Black and/or Latinx.
  • * Ability of participant to comprehend and communicate in written and spoken English, in order to complete surveys and participate in mentioning sessions and other interview (parents/caregivers do not need to have English fluency)
  • * Access to personal cellphone or tablet to participate in remote video sessions with the peer mentor
  • * Naïve to or not currently using CGM. "Current" use is defined as any CGM used for clinical management of T1D for \> 1 week within the last three months.
  • * Participants with a prior severe skin reaction to CGM sensor or adhesive.
  • * Current use of CGM
  • * Current or planned pregnancy
  • * Inability to comprehend or communicate in spoken/written English
  • * Subjects with other medical or mental health conditions that would, in the opinion of the investigators, interfere with the conduct of the study or present additional risk to the individual.

Ages Eligible for Study

13 Years to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Yale University,

Robin Whittemore, PhD, APRN, FAAN, PRINCIPAL_INVESTIGATOR, Yale School of Nursing

Stuart A Weinzimer, MD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2027-02